Cargando…
Accidental intoxications in toddlers: lack of cross-reactivity of vilazodone and its urinary metabolite M17 with drug of abuse screening immunoassays
BACKGROUND: Vilazodone is an FDA approved medication used to treat major depressive disorder. The authors describe two cases of accidental vilazodone exposure in toddlers who presented with symptoms similar to amphetamine exposure and also with unexplained positive amphetamine urine immunoassay drug...
Autores principales: | Martinez-Brokaw, Christina D., Radke, Joshua B., Pierce, Joshua G., Ehlers, Alexandra, Ekins, Sean, Wood, Kelly E., Maakestad, Jon, Rymer, Jacqueline A., Tamama, Kenichi, Krasowski, Matthew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379996/ https://www.ncbi.nlm.nih.gov/pubmed/30820187 http://dx.doi.org/10.1186/s12907-019-0084-9 |
Ejemplares similares
-
Diagnostic pitfalls and laboratory test interference after hydroxychloroquine intoxication: A case report
por: Radke, Joshua B., et al.
Publicado: (2019) -
Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction
por: Krasowski, Matthew D, et al.
Publicado: (2014) -
Data on hydroxychloroquine interference with urine laboratory testing
por: Kingery, Jennie M., et al.
Publicado: (2019) -
Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine
por: Krasowski, Matthew D, et al.
Publicado: (2009) -
Using cheminformatics to predict cross reactivity of “designer drugs” to their currently available immunoassays
por: Krasowski, Matthew D, et al.
Publicado: (2014)